Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis

OBJECTIVES: To compare drug survival in patients with axial spondyloarthritis treated with different TNF inhibitors in standard dosage. METHODS: Patients fulfilling the Assessment in SpondyloArthritis international Society classification criteria for axial spondyloarthritis in the Swiss Clinical Qua...

Descripción completa

Detalles Bibliográficos
Autores principales: Hebeisen, Monika, Scherer, Almut, Micheroli, Raphael, Nissen, Michael J., Tamborrini, Giorgio, Möller, Burkhard, Zufferey, Pascal, Exer, Pascale, Ciurea, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542531/
https://www.ncbi.nlm.nih.gov/pubmed/31145730
http://dx.doi.org/10.1371/journal.pone.0216746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542531/
https://www.ncbi.nlm.nih.gov/pubmed/31145730
http://dx.doi.org/10.1371/journal.pone.0216746

Ejemplares similares